Patent intelligence · US
US 11377421
Psychotropic agents and uses thereof
Psychotropic agents and uses thereof
Patent details — US 11377421
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 5, 2022
- Expiration
- Jun 30, 2042
- Applicant
- LB PHARMACEUTICALS INC.
- Claims
- 5
- CPC classes
- A61K, A61K31/166, A61K31/40, A61K45/06
Quick answer
US 11377421 (Psychotropic agents and uses thereof) is held by LB PHARMACEUTICALS INC.. Status: granted. Granted Jul 5, 2022. Expires Jun 30, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- LB PHARMACEUTICALS INC.
- Grant date
- Expiration
- Claims
- 5
- CPC classes
- A61K, A61K31/166, A61K31/40, A61K45/06, A61P, A61P25/18
More from LB PHARMACEUTICALS INC.
Related pharmaceutical patents in our USPTO index.
-
US 12060327
Psychotropic agents and uses thereof
granted -
US 11713295
Psychotropic agents and uses thereof
granted -
US 11040943
Psychotropic agents and uses thereof
granted -
US 10689338
Psychotropic agents and uses thereof
granted -
US 10259786
Psychotropic agents and uses thereof
granted -
US 10167256
Psychotrophic agents and uses thereof
granted
Frequently asked questions
What is US patent 11377421?
US 11377421 (Psychotropic agents and uses thereof) is held by LB PHARMACEUTICALS INC.. Status: granted. Granted Jul 5, 2022. Expires Jun 30, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11377421?
LB PHARMACEUTICALS INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does US 11377421 expire?
Our index shows an expiration date of Jun 30, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.